参考文献/References:
[1]WHO. World Health Organization Report: Comprehensive Cervical Cancer Control: a guide of essential practice [R]: World Health Organization Web site(2014).
[2]米颖,杨燕.腹腔镜卵巢移位手术对宫颈鳞癌患者放疗前作用研究 [J].国际医药卫生导报,2013,19(2):213-215.
[3]吴小华,李子庭,黄啸.放疗对早期子宫颈癌患者移位卵巢功能的影响 [J].中华妇产科杂志,2005,40 (4):220-222.
[4]王建六,张晓红,梁旭东.子宫颈癌患者卵巢腹腔内移位术后卵巢功能的评价 [J].中华妇产科杂志,2006,41(4):229-232.
[5]Gubbala K,Laios A,Gallos I,et al. Outcomes of ovarian transposition in gynaecological cancers:a systematic review and meta-analysis [J].J Ovarian Res,2014,7:69-79.
[6]MOAWAD N S, SANTAMARIA E, RHOTON-VLASAK A A. Laparoscopic ovarian transposition before pelvic cancer treatment: ovarian function and fertility preservation [J]. Journal of Minimally Invasive Gynecology, 2017, 24(1): 28-35.
[7]URRUTIA M, ARAYA A, RIVERA S, et al. A predictive model for the quality of sexual life in hysterectomized women [J]. Revista Medica de Chile, 2007, 135(3): 317-325.
[8]MOSSA B, SCHIMBERNI M, DI BENEDETTO L, et al. Ovarian transposition in young women and fertility sparing [J]. European Review for Medical and Pharmacological Sciences, 2015, 19(18): 3418-3425.
[9]YOON A, LEE Y Y, PARK W, et al. Correlation between location of transposed ovary and function in cervical cancer patients who underwent radical hysterectomy [J]. Int J Gynecol Cancer, 2015, 25(4): 688-693.
[10]SALIH S M, ALBAYRAK S, SEO S, et al. Diminished utilization of in vitro fertilization following ovarian transposition in cervical cancer patients [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2015, 60 (7/8): 345-353.
[11]BLUMENFELD Z, EVRON A. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists [J]. Expert Opinion on Pharmacotherapy, 2015, 16(7): 1009-1020.
[12]LUISI S, ORLANDINI C, BILIOTTI G, et al. Hormone replacement therapy in menopause and in premature ovarian insufficiency [J]. Minerva Ginecologica, 2013, 65(6): 607-620.
相似文献/References:
[1]林文毅,李荣建,赖娜,等.15653例宫颈液基薄层细胞学检查回顾性分析[J].中国计划生育和妇产科,2010,(03):0.
[2]石一复,李娟清.人乳头状瘤病毒及其预防性疫苗的现况[J].中国计划生育和妇产科,2011,(02):0.
[3]梁志清.腹腔镜广泛子宫切除术泌尿系统并发症的预防与处理[J].中国计划生育和妇产科,2012,(01):0.
LIANG Zhi-qing.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(12):0.
[4]姜志欣,蔡瑞芬,林宁,等.人群大样本子宫颈癌筛查中宫颈涂片的质量控制[J].中国计划生育和妇产科,2012,(01):0.
JIANG Zhi-xin,CAI Rui-fen,LIN Ning,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(12):0.
[5]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[6]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[7]魏秀莉.大麻素受体2与子宫颈癌组织内浸润T细胞亚群的关系[J].中国计划生育和妇产科,2017,(9):70.
WEI Xiu-li.The relationship between cannabinoid receptor 2 and infiltrating T-cell subsets in cervical cancer tissue[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):70.